Research programme: anti-infectives - Novavax
Latest Information Update: 24 Oct 2021
At a glance
- Originator California Pacific Medical Center; St. Marys Medical Center
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections; Parasitic infections
Most Recent Events
- 04 Dec 2003 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 04 Dec 2003 Discontinued - Preclinical for Parasitic infections in USA (unspecified route)
- 12 May 2000 Preclinical development for Bacterial infections in USA (Unknown route)